Current HIV research · 2026
Metastasis-Specific Biomarker SPP1 and its Characterization in Colorectal Cancer with HIV Infection.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gao Yuxue, Guan Yuanyue, Yang Pengxiang, Ning Qiqi, Chang Jing, Chen Dexi, Zhang Yulin, Zhang Yuening
Аннотация
INTRODUCTION: Secreted phosphoprotein 1 (SPP1) is upregulated in cancers, but its role in metastatic colorectal cancer (CRC) and expression in HIV-associated CRC remain unclear.
METHODS: Transcriptomic data from the GEO and TCGA databases were analyzed. Metastasisspecific genes were identified. SPP1-associated functions were explored using GO enrichment, KEGG pathway analysis, and GSVA. Prognostic value was assessed. SPP1 expression was evaluated in 30 CRC specimens (15 HIV-positive, 15 HIV-negative) via immunohistochemistry.
RESULTS: SPP1 exhibited a metastasis-specific expression pattern. High SPP1 correlated with significantly elevated immune cell infiltration and adverse clinicopathological features: older age, mucinous adenocarcinoma, lymphatic invasion, advanced stage, high TN stage, MSI-H status, absence of polyps, and poor prognosis. GO enrichment linked SPP1 to extracellular matrix organization, cell adhesion, immune response, inflammation, and receptor binding. KEGG analysis showed enrichment in HIV-1 infection pathways. However, overall SPP1 expression did not significantly differ between HIV-positive and HIV-negative CRC tissues. Diffuse SPP1 protein expression was noted in an HIV-positive signet-ring cell carcinoma.
DISCUSSION: SPP1 is a pivotal driver of CRC metastasis and immune regulation in the tumor microenvironment, and is associated with aggressive disease and poor outcomes. It shows strong potential as a prognostic biomarker. While HIV status did not broadly alter SPP1 expression, its specific pattern in certain HIV-associated carcinomas requires further study.
CONCLUSION: SPP1 critically mediates metastasis and immune regulation in CRC and independently predicts poor survival. Its prognostic value is confirmed, warranting investigation into its role in specific HIV-related carcinomas.
METHODS: Transcriptomic data from the GEO and TCGA databases were analyzed. Metastasisspecific genes were identified. SPP1-associated functions were explored using GO enrichment, KEGG pathway analysis, and GSVA. Prognostic value was assessed. SPP1 expression was evaluated in 30 CRC specimens (15 HIV-positive, 15 HIV-negative) via immunohistochemistry.
RESULTS: SPP1 exhibited a metastasis-specific expression pattern. High SPP1 correlated with significantly elevated immune cell infiltration and adverse clinicopathological features: older age, mucinous adenocarcinoma, lymphatic invasion, advanced stage, high TN stage, MSI-H status, absence of polyps, and poor prognosis. GO enrichment linked SPP1 to extracellular matrix organization, cell adhesion, immune response, inflammation, and receptor binding. KEGG analysis showed enrichment in HIV-1 infection pathways. However, overall SPP1 expression did not significantly differ between HIV-positive and HIV-negative CRC tissues. Diffuse SPP1 protein expression was noted in an HIV-positive signet-ring cell carcinoma.
DISCUSSION: SPP1 is a pivotal driver of CRC metastasis and immune regulation in the tumor microenvironment, and is associated with aggressive disease and poor outcomes. It shows strong potential as a prognostic biomarker. While HIV status did not broadly alter SPP1 expression, its specific pattern in certain HIV-associated carcinomas requires further study.
CONCLUSION: SPP1 critically mediates metastasis and immune regulation in CRC and independently predicts poor survival. Its prognostic value is confirmed, warranting investigation into its role in specific HIV-related carcinomas.